Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin
Publication date: September 2020Source: Journal of Global Antimicrobial Resistance, Volume 22Author(s): Jonah A. Moore, Michaela Meakin, Mikaela H. Earl, Tiffany M. Kummer, Jeremy P. McAleer, Timothy E. Long
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research
More News: Antimicrobial Resistance | Cancidas | Caspofungin | Infectious Diseases | MRSA | Superbugs